Travere Therapeutics Inc.

Travere Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Travere Therapeutics Inc. net income for the quarter ending March 31, 2026 was -37.1 M, a 10.00% decrease year-over-year.
• Travere Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -65.4 M, a 40.86% decrease year-over-year.
• Travere Therapeutics Inc. annual net income for 2025 was -25.5 M, a 92.06% decrease from 2024.
• Travere Therapeutics Inc. annual net income for 2024 was -321.5 M, a 188.64% increase from 2023.
• Travere Therapeutics Inc. annual net income for 2023 was -111.4 M, a 60.00% decrease from 2022.
• Travere Therapeutics Inc. annual net income for 2022 was -278.5 M.